"In recent years, the level of innovation in domestic medical devices has improved, but the original innovation capability is still insufficient. This is the biggest bottleneck restricting the development of domestic medical devices." Recently, it was co-sponsored by the Chinese Medical Association Cardiovascular Branch and the People's Political Consultative Conference Newspaper. At the salon of “Innovative Development of Domestic Medical Devicesâ€, Huo Yong, member of the National Committee of the Chinese People's Political Consultative Conference and chairman of the Chinese Medical Association Cardiovascular Disease Branch, said that it is necessary to work together to improve the level of innovation in domestic medical devices, especially for doctors. Encourage medical staff to participate in medical device development Huo Yong introduced that in 2013, the number of cardiac interventions in China exceeded 450,000, and nearly 700,000 stents were used. Among them, 3/4 of the market has been occupied by domestic stents, but the original things are not in our hands. Although we may have some local or detailed improvements, such as the earliest stents we produced in the world with degradable drug coatings, there is no real whole original product. Huo Yong said: "In terms of medical devices, innovation is the source. Just like any other industry, innovation is productivity, but the problem is that the biggest problem in the medical device industry innovation in our country is the lack of source innovation. Even now medical devices There are certain markets and certain products, but most of these products are based on how to do it abroad, we follow. Another, an innovation of engineering and technical personnel within a certain range. But this innovation is not at the source, because all medical care From the formation of research and development, to the production of products, and finally to the market, there must be new innovations from the source. This is obviously not enough in our country." Huo Yong pointed out that medical device innovation mainly comes from doctors. Businesses may also have good ideas, but because he is not in the clinic, it is impossible to perform surgery on patients every day, so the demand for equipment and the lack of existence will not be as clear as doctors. But now Chinese doctors can't even see patients every day, they don't have time to innovate, they lack this kind of consciousness and tradition, and more importantly, they lack motivation, such as how to protect intellectual property rights, how to distribute benefits, and so on. "At present, the People's Hospital of Jiangsu Province has carried out useful explorations. They stipulate that doctors' innovations are owned by themselves, and 80% of the benefits are attributed to themselves." Huo Yong suggested that policies should also be introduced at the national level to encourage clinicians to participate in medical devices. Research and development. At the same time, social capital is encouraged to participate in the research and development of medical devices, including the participation of venture capital. Domestically imported medical devices should be of the same quality "China's medical device market is dominated by imported products. Even domestically produced medical devices of superior quality and reasonable price are still relatively low in hospitals." Yu Guangyan, member of the National Committee of the Chinese People's Political Consultative Conference and former dean of Peking University Stomatological Hospital, said that there are enterprises here. The reasons, for example, the quality of some domestic medical devices is not good or the stability is insufficient, some manufacturers or sales departments have poor after-sales service, and user satisfaction is low. Of course, there are also reasons, such as patients and their families often require the use of imported medical equipment, medical staff are not actively using domestic products. "There are some problems in the national policy orientation. For example, the domestically-imported import price of the bidding price is different." The chairman of the Liaoning Provincial Political Consultative Conference and the chairman of Liaoning Biomedical Materials Research and Development Center Co., Ltd. said that the current domestic cardiac stent and imported cardiac stent are at the technical level. There is no difference in the price, but in the bidding pricing, domestic and imported will have a gap of 1 to 2 times; in the case of orthopedic implants, the gap can reach 2 to 3 times. In addition, there is no difference in the pricing of generic products and innovative products. The current bidding pricing policy seriously dampens the enthusiasm of enterprise innovation. In the long run, it is not conducive to the healthy development of China's medical device industry. Melatonin Capsules,Melatonin Soft Capsule,Rhodiola Capsules,Folic Acid Powder Xi'an complex bio-tech CO.,LTD. , https://www.complexpowder.com